⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Global Demand Spurs Competition in CAR T-Cell Therapy for Multiple Myeloma
globenewswire.com
BMY
JNJ
NVS
GILD
New Symptom-Management Guide Offers Practical Support for People Undergoing Metastatic Breast Cancer Treatment
prnewswire.com
GILD
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference
globenewswire.com
AMGN
REGN
GILD
BMY
AZN
NVS
ARGX
BIIB
BBIO
SRRK
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
businesswire.com
ACLX
GILD
Allergy Diagnostics and Therapeutics Market Forecast 2025-2033 - Urbanization and Pollution Drive Allergy Rates, Accelerating Market Expansion at a 9.7% CAGR - ResearchAndMarkets.com
businesswire.com
GILD
Immunotherapy Drugs Research Report 2025: $526.5 Bn Market Opportunities, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2034
globenewswire.com
AMGN
PFE
JNJ
BMY
GILD
MRK
MDT
ADAP
CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players
globenewswire.com
BMY
GILD
NVS
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
JAZZ
PRE
ABBV
AMGN
GILD
BMY
AZN
INCY
PFE
CELC
American Cancer Society Updates Cervical Cancer Screening Guideline: Major Changes Include Self-Collection for HPV Testing and Guidance on Exiting Screening
prnewswire.com
MRK
BMY
GILD
Alors que le nombre de décès d'enfants devrait augmenter pour la première fois au cours de ce siècle, la Fondation Gates exhorte les dirigeants mondiaux à cibler les ressources limitées là où elles permettent de sauver le plus de vies. USA - Français USA
prnewswire.com
BMY
JNJ
PFE
MRK
GILD